171 related articles for article (PubMed ID: 31732566)
1. Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.
Zhou Z; Müller MLTM; Kanel P; Chua J; Kotagal V; Kaufer DI; Albin RL; Frey KA; Bohnen NI
Neurology; 2020 Jan; 94(4):e376-e383. PubMed ID: 31732566
[TBL] [Abstract][Full Text] [Related]
2. Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.
Shah N; Frey KA; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Bohnen NI
Mov Disord; 2016 Jan; 31(1):111-7. PubMed ID: 26380951
[TBL] [Abstract][Full Text] [Related]
3. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Constantine GM; Scott PJ; Albin RL; Müller ML
Mov Disord; 2014 Aug; 29(9):1118-24. PubMed ID: 24909584
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography.
Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ
JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging and clinical predictors of fatigue in Parkinson disease.
Chou KL; Kotagal V; Bohnen NI
Parkinsonism Relat Disord; 2016 Feb; 23():45-9. PubMed ID: 26683744
[TBL] [Abstract][Full Text] [Related]
6. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
[TBL] [Abstract][Full Text] [Related]
7. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.
Petrou M; Bohnen NI; Müller ML; Koeppe RA; Albin RL; Frey KA
Neurology; 2012 Sep; 79(11):1161-7. PubMed ID: 22933741
[TBL] [Abstract][Full Text] [Related]
8. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.
Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T
J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
[TBL] [Abstract][Full Text] [Related]
10. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
Marshall GA; Gatchel JR; Donovan NJ; Muniz MC; Schultz AP; Becker JA; Chhatwal JP; Hanseeuw BJ; Papp KV; Amariglio RE; Rentz DM; Sperling RA; Johnson KA
J Alzheimers Dis; 2019; 67(2):757-768. PubMed ID: 30689584
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.
Kotagal V; Bohnen NI; Müller ML; Frey KA; Albin RL
J Parkinsons Dis; 2017; 7(1):143-147. PubMed ID: 28106566
[TBL] [Abstract][Full Text] [Related]
12. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
Kotagal V; Albin RL; Müller ML; Koeppe RA; Chervin RD; Frey KA; Bohnen NI
Ann Neurol; 2012 Apr; 71(4):560-8. PubMed ID: 22522445
[TBL] [Abstract][Full Text] [Related]
13. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia.
Müller ML; Frey KA; Petrou M; Kotagal V; Koeppe RA; Albin RL; Bohnen NI
Mov Disord; 2013 Mar; 28(3):296-301. PubMed ID: 23239424
[TBL] [Abstract][Full Text] [Related]
14. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
16. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
[TBL] [Abstract][Full Text] [Related]
17. Neural correlates of apathy in late-life depression: a pilot [
Eyre HA; Siddarth P; van Dyk K; St Cyr N; Baune BT; Barrio JR; Small GW; Lavretsky H
Psychogeriatrics; 2017 May; 17(3):186-193. PubMed ID: 28130887
[TBL] [Abstract][Full Text] [Related]
18. Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
Mori T; Shimada H; Shinotoh H; Hirano S; Eguchi Y; Yamada M; Fukuhara R; Tanimukai S; Zhang MR; Kuwabara S; Ueno S; Suhara T
J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):449-55. PubMed ID: 24133289
[TBL] [Abstract][Full Text] [Related]
19. Gait speed in Parkinson disease correlates with cholinergic degeneration.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Scott PJ; Albin RL; Müller ML
Neurology; 2013 Oct; 81(18):1611-6. PubMed ID: 24078735
[TBL] [Abstract][Full Text] [Related]
20. History of falls in Parkinson disease is associated with reduced cholinergic activity.
Bohnen NI; Müller ML; Koeppe RA; Studenski SA; Kilbourn MA; Frey KA; Albin RL
Neurology; 2009 Nov; 73(20):1670-6. PubMed ID: 19917989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
